Cargando…
Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis
Accompanying the increased use of biologic and non-biologic antirheumatic agents, patients with RA have been exposed to an increased risk of Pneumocystis jirovecii infection, which causes acute fulminant P. jirovecii pneumonia (PCP). Mortality in this population is higher than in HIV-infected indivi...
Autores principales: | Mori, Shunsuke, Sugimoto, Mineharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510430/ https://www.ncbi.nlm.nih.gov/pubmed/23001613 http://dx.doi.org/10.1093/rheumatology/kes244 |
Ejemplares similares
-
Pneumocystis jirovecii Pneumonia in Rheumatoid Arthritis Patients: Risks and Prophylaxis Recommendations
por: Mori, Shunsuke, et al.
Publicado: (2015) -
Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based Review
por: Mori, Shunsuke, et al.
Publicado: (2015) -
Pneumocystis jirovecii Pneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept
por: Ospina, Fabio E., et al.
Publicado: (2014) -
Small airway obstruction in patients with rheumatoid arthritis
por: Mori, Shunsuke, et al.
Publicado: (2010) -
Therapy and Management of Pneumocystis jirovecii Infection
por: White, P. Lewis, et al.
Publicado: (2018)